{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:18:32Z","timestamp":1772853512618,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T00:00:00Z","timestamp":1228953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The most prevalent primary immunodeficiency is common variable immunodeficiency (CVID). Mutations have been described in four genes, ICOS, CD19, BAFF-R and TNFRSF13B (encoding TACI), together associated with 10\u201315% of CVID cases. We investigated a family with CVID and identified the heterozygous C104R TNFRSF13B mutation in two of the three index-children with CVID, a mother with selective immunoglobulin A deficiency, a mother with recurrent infections and a healthy grandfather. Remarkably, we did not find the TNFRSF13B mutation in the third index-child with CVID, despite his hypogammaglobulinaemia and decreased response to unconjugated pneumococcal vaccine. This family illustrates that TNFRSF13B mutations induce disease susceptibility rather than cause disease directly. Apparently, other genetic or environmental factors, still to be identified, contributed to the development of CVID in this family. Consequently, TNFRSF13B mutations must be interpreted with caution in the clinical setting.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03863.x","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T11:32:26Z","timestamp":1228995146000},"page":"35-39","source":"Crossref","is-referenced-by-count":49,"title":["<i>TACI<\/i> mutations and disease susceptibility in patients with common variable immunodeficiency"],"prefix":"10.1093","volume":"156","author":[{"given":"A E J","family":"Poodt","sequence":"first","affiliation":[{"name":"Department Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J A","family":"Driessen","sequence":"additional","affiliation":[{"name":"Department Pediatrics, Erasmus MC, Sophia Children's Hospital, Rotterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"De Klein","sequence":"additional","affiliation":[{"name":"Department Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J M","family":"Van Dongen","sequence":"additional","affiliation":[{"name":"Department Immunology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Van Der Burg","sequence":"additional","affiliation":[{"name":"Department Immunology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"De Vries","sequence":"additional","affiliation":[{"name":"Department Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,12,11]]},"reference":[{"key":"2021122708533606400_b1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","article-title":"Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review","volume":"149","author":"Wood","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021122708533606400_b2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"2021122708533606400_b3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.all.0000191888.97397.b3","article-title":"Tackling the heterogeneity of CVID","volume":"5","author":"Goldacker","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2021122708533606400_b4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","article-title":"Common variable immunodeficiency: a review","volume":"3","author":"Di Renzo","year":"2004","journal-title":"Clin Exp Med"},{"key":"2021122708533606400_b5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"2021122708533606400_b6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"2021122708533606400_b7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol"},{"key":"2021122708533606400_b8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","article-title":"ICOS deficiency in patients with common variable immunodeficiency","volume":"113","author":"Salzer","year":"2004","journal-title":"Clin Immunol"},{"key":"2021122708533606400_b9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"Van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122708533606400_b10","article-title":"Finally found: human BAFF-R deficiency causes CVID","volume-title":"XIth Meeting of the European Society for Immunodeficiencies","author":"Warnatz","year":"2004"},{"key":"2021122708533606400_b11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.gene.6364431","article-title":"Novel mutations in a Japanese patient with CD19 deficiency","volume":"8","author":"Kanegane","year":"2007","journal-title":"Genes Immun"},{"key":"2021122708533606400_b12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gde.2007.04.002","article-title":"Deconstructing common variable immunodeficiency by genetic analysis","volume":"17","author":"Schaffer","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"2021122708533606400_b13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/eji.200636914","article-title":"To switch or not to switch \u2013 the opposing roles of TACI in terminal B cell differentiation","volume":"37","author":"Salzer","year":"2007","journal-title":"Eur J Immunol"},{"key":"2021122708533606400_b14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/eji.200636623","article-title":"TACI attenuates antibody production costimulated by BAFF-R and CD40","volume":"37","author":"Sakurai","year":"2007","journal-title":"Eur J Immunol"},{"key":"2021122708533606400_b15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nat Genet"},{"key":"2021122708533606400_b16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0092-1157(89)90009-7","article-title":"Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro toxin-binding inhibition (ToBI) test","volume":"17","author":"Hendriksen","year":"1989","journal-title":"J Biol Stand"},{"key":"2021122708533606400_b17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3201\/eid0505.990511","article-title":"Diphtheria antitoxin levels in the Netherlands: a population-based study","volume":"5","author":"De Melker","year":"1999","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03863.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/1\/35\/41925343\/j.1365-2249.2008.03863.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/1\/35\/41925343\/j.1365-2249.2008.03863.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:22:36Z","timestamp":1641054156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/156\/1\/35\/6425441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,11]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,12,11]]},"published-print":{"date-parts":[[2009,3,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03863.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,4]]},"published":{"date-parts":[[2008,12,11]]}}}